Clinical Trial Detail

NCT ID NCT03203525
Title Study of the NovoTTF-100L System to Enhance Antitumor Activity in Patients With Predominant Hepatic Metastatic Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

colorectal cancer

Advanced Solid Tumor

Therapies

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Bevacizumab + Doxorubicin + Temsirolimus

Age Groups: adult senior

No variant requirements are available.